Search Results - "Giannoni, Federico"

Refine Results
  1. 1

    Drug-Resistant Tuberculosis 2020: Where We Stand by Iacobino, Angelo, Fattorini, Lanfranco, Giannoni, Federico

    Published in Applied sciences (01-03-2020)
    “…The control of tuberculosis (TB) is hampered by the emergence of multidrug-resistant (MDR) Mycobacterium tuberculosis (Mtb) strains, defined as resistant to at…”
    Get full text
    Journal Article
  2. 2

    Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH by Iacobino, Angelo, Piccaro, Giovanni, Giannoni, Federico, Mustazzolu, Alessandro, Fattorini, Lanfranco

    Published in Antimicrobial agents and chemotherapy (01-03-2017)
    “…The activities of rifampin, rifapentine, bedaquiline, PA-824, clofazimine, nitazoxanide, isoniazid, amikacin, moxifloxacin, niclosamide, thioridazine, and…”
    Get full text
    Journal Article
  3. 3

    Activities of Drug Combinations against Mycobacterium tuberculosis Grown in Aerobic and Hypoxic Acidic Conditions by PICCARO, Giovanni, GIANNONI, Federico, FILIPPINI, Perla, MUSTAZZOLU, Alessandro, FATTORINI, Lanfranco

    Published in Antimicrobial Agents and Chemotherapy (01-03-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand by Lanni, Alessio, Iacobino, Angelo, Fattorini, Lanfranco, Giannoni, Federico

    Published in Microorganisms (Basel) (06-06-2023)
    “…The lungs of tuberculosis (TB) patients contain a spectrum of granulomatous lesions, ranging from solid and well-vascularized cellular granulomas to avascular…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Activity of DNA-targeted C8-linked pyrrolobenzodiazepine–heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions by Iacobino, Angelo, Giannoni, Federico, Fattorini, Lanfranco, Brucoli, Federico

    Published in Journal of antibiotics (01-09-2018)
    “…Mycobacterium tuberculosis ( Mtb ) is the aetiological agent of tuberculosis, the leading cause of death worldwide from a single infectious agent. Mtb is a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation by Iona, Elisabetta, Pardini, Manuela, Mustazzolu, Alessandro, Piccaro, Giovanni, Nisini, Roberto, Fattorini, Lanfranco, Giannoni, Federico

    Published in The journal of microbiology (01-08-2016)
    “…The physiology of dormant Mycobacterium tuberculosis was studied in detail by examining the gene expression of 51 genes using quantitative…”
    Get full text
    Journal Article
  10. 10

    Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner by Iacobino, Angelo, Piccaro, Giovanni, Pardini, Manuela, Fattorini, Lanfranco, Giannoni, Federico

    Published in Microorganisms (Basel) (27-01-2021)
    “…Previous studies on demonstrated that sub-minimum inhibitory concentration (MIC) of fluoroquinolones induced the SOS response, increasing drug tolerance. We…”
    Get full text
    Journal Article
  11. 11

    Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli by Iacobino, Angelo, Piccaro, Giovanni, Giannoni, Federico, Mustazzolu, Alessandro, Fattorini, Lanfranco

    Published in International journal of mycobacteriology (01-07-2017)
    “…Current tuberculosis (TB) treatment requires 6 months of combination therapy with isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and ethambutol for…”
    Get full text
    Journal Article
  12. 12

    Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions by Lanni, Alessio, Borroni, Emanuele, Iacobino, Angelo, Russo, Cristina, Gentile, Leonarda, Fattorini, Lanfranco, Giannoni, Federico

    Published in Microorganisms (Basel) (14-07-2022)
    “…Infections caused by Mycobacterium abscessus (Mab), an environmental non-tuberculous mycobacterium, are difficult to eradicate from patients with pulmonary…”
    Get full text
    Journal Article
  13. 13

    Targeting dormant bacilli to fight tuberculosis by Fattorini, Lanfranco, Piccaro, Giovanni, Mustazzolu, Alessandro, Giannoni, Federico

    “…Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb), which kills about 2 million people annually. Furthermore, 2 billion…”
    Get full text
    Journal Article
  14. 14

    Endogenous PGE2 promotes the induction of human Th17 responses by fungal β-glucan by Gagliardi, Maria Cristina, Teloni, Raffaela, Mariotti, Sabrina, Bromuro, Carla, Chiani, Paola, Romagnoli, Giulia, Giannoni, Federico, Torosantucci, Antonella, Nisini, Roberto

    Published in Journal of leukocyte biology (01-11-2010)
    “…C. albicans β‐glucan induces PGE2 production by human DC and promotes Th17 cell expansion. The interaction of PAMPs with cells of the innate immune system…”
    Get full text
    Journal Article
  15. 15

    Metronidazole plus Rifampin Sterilizes Long-Term Dormant Mycobacterium tuberculosis by IONA, Elisabetta, GIANNONI, Federico, PARDINI, Manuela, BRUNORI, Lara, OREFICI, Graziella, FATTORINI, Lanfranco

    Published in Antimicrobial Agents and Chemotherapy (01-04-2007)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Mycobacteria Exploit p38 Signaling To Affect CD1 Expression and Lipid Antigen Presentation by Human Dendritic Cells by Gagliardi, Maria Cristina, Teloni, Raffaela, Giannoni, Federico, Mariotti, Sabrina, Remoli, Maria Elena, Sargentini, Valeria, Videtta, Melissa, Pardini, Manuela, De Libero, Gennaro, Coccia, Eliana Marina, Nisini, Roberto

    Published in Infection and Immunity (01-11-2009)
    “…Group I CD1 proteins are specialized antigen-presenting molecules that present both microbial and self lipid antigens to CD1-restricted α/β T lymphocytes. The…”
    Get full text
    Journal Article
  17. 17

    Evaluation of a New Line Probe Assay for Rapid Identification of gyrA Mutations in Mycobacterium tuberculosis by GIANNONI, Federico, IONA, Elisabetta, SEMENTILLI, Federica, BRUNORI, Lara, PARDINI, Manuela, BATTISTA MIGLIORI, Giovanni, OREFICI, Graziella, FATTORINI, Lanfranco

    Published in Antimicrobial Agents and Chemotherapy (01-07-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Isolation of Nocardia asiatica from Cutaneous Ulcers of a Human Immunodeficiency Virus-Infected Patient in Italy by Iona, Elisabetta, Giannoni, Federico, Brunori, Lara, de Gennaro, Michele, Mattei, Romano, Fattorini, Lanfranco

    Published in Journal of Clinical Microbiology (01-06-2007)
    “…A strain of Nocardia was isolated from cutaneous ulcers of a human immunodeficiency virus-infected patient in Italy. Comparative 16S rRNA gene sequence…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Drug Resistance Evolution of a Mycobacterium tuberculosis Strain from a Noncompliant Patient by Meacci, Francesca, Orrù, Germano, Iona, Elisabetta, Giannoni, Federico, Piersimoni, Claudio, Pozzi, Gianni, Fattorini, Lanfranco, Oggioni, Marco R

    Published in Journal of Clinical Microbiology (01-07-2005)
    “…The emergence and spread of multidrug-resistant (MDR) Mycobacterium tuberculosis (MT) represents a worldwide health care problem because of the difficulty in…”
    Get full text
    Journal Article